BlackRock Advisors’s aTyr Pharma ATYR Stock Holding History

BlackRock Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$454K	Sell	15,097 -1,461	-9%	-$59.9K	﹤0.01%	2252
2016 Q3	$737K	Sell	16,558 -900	-5%	-$38.9K	﹤0.01%	1971
2016 Q2	$679K	Buy	17,458 +17,341	+14,821%	+$806K	﹤0.01%	1954
2016 Q1	$6K	Hold	117	–	–	﹤0.01%	3654
2015 Q4	$16K	Sell	117 -102	-47%	-$14.5K	﹤0.01%	3548
2015 Q3	$31K	Hold	219	–	–	﹤0.01%	3415
2015 Q2	$57K	Buy	+219	New	+$68K	﹤0.01%	3314

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GHCM

Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

MCIM

Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return

BlackRock Advisors's ATYR Position: Q4 2016 in Review

BlackRock Advisors reduced its aTyr Pharma (ATYR) stake by 8.8% in Q4 2016, selling an estimated $59.9K and leaving 15,097 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

BlackRock Advisors first reported a position in ATYR in Q2 2015 and has held it in 7 quarters since. The position peaked at $737K in Q3 2016. 52 funds tracked by Wall St. Rank hold ATYR as of Q4 2016.

BlackRock Advisors held 15,097 shares of aTyr Pharma worth $454K as of Q4 2016.
BlackRock Advisors sold 1,461 aTyr Pharma shares in Q4 2016, an estimated $59.9K.
aTyr Pharma made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2252 holding.
BlackRock Advisors first reported a position in aTyr Pharma in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's aTyr Pharma position peaked at $737K in Q3 2016.
52 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.